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Pregnant women who are obese or whose gestational weight gain is above recommended limits are at increased risk of 
obstetric complications,1 but there may also be longer term 
consequences for the health of the child.2 A high maternal pre-
pregnancy body mass index and excessive gestational weight 
gain have been frequently independently associated with a 
heightened risk of offspring metabolic dysfunction and obe-
sity3 and there is increasing evidence to suggest that cardiovas-
cular function may also be compromised.4
Studies of maternal calorie-rich diets and obesity in rodents, 
sheep, and nonhuman primates have provided unequivocal evi-
dence for persistent and adverse influences on the offspring.5 
We and others have repeatedly observed cardiovascular dys-
function secondary to maternal obesity in animal models.6–8 
Previously, we observed that juvenile offspring of obese rats 
have aberrant autonomic control of blood pressure (BP) result-
ing in hypertension, which occurs before the development of 
increased adiposity and persists into adulthood,7 and that these 
animals demonstrate hyperphagia and leptin resistance asso-
ciated with a functional, structural, and cell-signaling deficit 
in leptin-sensitive processes in the arcuate nucleus and para-
ventricular nucleus of the hypothalamus.9 The cardiovascu-
lar response to exogenous leptin, which is mediated through 
hypothalamic sympathetic efferent activity,10,11 was, con-
versely, enhanced.7 This differential response to leptin, some-
times termed selective leptin resistance, had been observed 
in rodents, but previously only in association with chronic 
obesity.12 We also reported that the offspring of obese dams 
(OffOb) exhibit an exaggerated and prolonged physiological 
postnatal serum leptin surge,9 known to play a critical role in 
the development of the normal rodent hypothalamus.13 We 
hypothesized that neonatal exposure to supranormal leptin 
concentrations during this important window of hypothalamic 
plasticity may play a causal role in offspring cardiovascular 
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dysfunction. We have, therefore, investigated the influence of 
exogenous leptin administration in neonatal rats on parameters 
of cardiovascular function and control measured in juvenile 
and adult life. Because the heart weight is increased in off-
spring of obese rats9,14 and mice15 and because leptin has been 
implicated in neonatal rodent cardiomyocyte proliferation and 
remodeling,16,17 we also studied the morphology of the heart, 
and cardiac function as assessed in vivo and ex vivo.
Methods
Animals
Standard principles of laboratory animal care were used and all 
procedures approved in accordance with the United Kingdom 
Government Home Office Animals (Specific Procedures) Act, 1986 
(PPL70/7090) and King’s College London Animal Ethical Review 
Process Committee.
Female Sprague-Dawley rats (Harlan Laboratories) were housed 
under controlled conditions (light exposure, 07:00–19:00 hours; 
21±2°C; 40%–50% humidity) and during mating and breeding main-
tained on a breeding diet (RM3, Special Diet Services). Forty-eight 
hours after delivery, litter size was standardized to 8 pups (equal num-
bers, male and female) and the litters randomly assigned to leptin 
(L-Tx; n=12) or saline (S-Tx; n=12) treatment. Leptin (3 mg/kg; 
PeproTech Ltd) or saline vehicle was administrated intraperitoneally 
twice daily (10:00 hours, 16:00 hours) from postnatal day (PD) 9 un-
til PD15. Offspring were weaned (day 21) onto standard chow and 
euthanized at 30 days, 2 and 12 months of age. Blood was collected 
by cardiac puncture. Inguinal white adipose tissue, the heart, and the 
liver were weighed and cryopreserved. A separate cohort of L-Tx and 
S-Tx litters were euthanized by decapitation at PD 2, 6, 7, 8, 9, 11, 14, 
and 20, 4 hours after the first leptin injection to obtain organ weights 
and serum for leptin analysis.
Leptin Challenge
Animals were challenged with leptin at 30 days (juvenile) and 2 
months of age (adult) after an overnight fast as described.9 A single 
bolus dose of recombinant rat leptin (10 mg/kg, IP) or saline vehicle 
was administrated at 10:00 hours immediately before food restora-
tion. The feeding and weight responses to leptin were assessed by 
measuring the change in body weight and food intake during the 
24-hour period after the injection.
Radiotelemetry
Radiotelemetry methods have been described previously.7 Briefly, 
juvenile rats were implanted with a mouse transmitter (PA-C10, Data 
Sciences International [DSI]) in the aortic arch.6 In adults, the DSI rat 
telemetry probe (PA-C40) was placed in the descending abdominal 
aorta.7 Heart rate variability (HRV) was analyzed from the telemetry 
record. Cardiovascular response to restraint stress was recorded for 
20 minutes with 120-minute recovery. Responses to a combination of 
intraperitoneal terazosin (10 mg/kg) and propranolol (10 mg/kg), or 
to leptin (10 mg/kg) were recorded.7 Spontaneous locomotor activity 
(counts of lateral movements in the cage) was monitored and analyzed 
using DataScience Dataquest software and expressed in arbitrary units.
Echocardiography
Left ventricular (LV) systolic function and chamber dimension were 
determined in vivo in 30-day and 12-month-old rats. M-mode trac-
ings were recorded from the short-axis view at the high papillary 
muscle level using a high-resolution Vevo 770 echocardiography sys-
tem (RMV707B, VisualSonics, Toronto, ON, Canada; see the online-
only Data Supplement).
Isolated Perfused Heart Preparation
As LV function, assessed using electrocardiography, is load- and 
heart rate–dependent, we assessed LV function and remodeling ex 
vivo at 30 days and 5 months of age, using isolated Langendorff heart 
preparations (see online-only Data Supplement).
Cardiomyocyte Morphology
Midventricular sections (7 µm) of paraformaldehyde fixed hearts 
were stained with laminin for determination of cardiomyocyte num-
ber and mean cardiomyocyte cross-sectional area. Sections were also 
stained with hematoxylin and eosin and Masson trichrome to estimate 
fibrosis (see online-only Data Supplement).
Analyses
Leptin and Insulin
The serum leptin and insulin concentrations were measured by 
ELISA (Crystal Chem Inc, Downers Grove, IL)
Renal Tissue Norepinephrine Content
The left kidney was homogenized in HCl (0.01 mol/L) with EDTA 
(1 mmol/L) and sodium metabisulfite (4 mmol/L) at day 30. After 
centrifugation (8000g; 30 minutes), the supernatant norepinephrine 
(NE) concentration was measured by ELISA (ALPCO Diagnostics, 
Salem, NH). NE content was expressed as nanogram per gram of 
renal tissue.
Data and Statistical Analysis
Data are presented as mean±SEM and analyzed using Student t test 
and 1-way ANOVA when appropriate. Cardiovascular analysis was 
performed by 1-way ANOVA for repeated measurements followed 
by the Tukey post hoc test. Where no significant differences between 
male and female data were observed using 2-way ANOVA, data were 
combined. Analysis of myocyte cross-sectional area (each animal 
given equal importance) was performed using linear regression with 
100 measurements per animal, 4 sections per animal. Statistical sig-
nificance was accepted as P<0.05.
Results
Organ Weight and Fat Mass
Neonatal leptin injection at PD9 to PD15 increased the serum 
leptin concentration ≈5 fold compared with saline treatment, 
when measured 4 hours postintraperitoneal injection (Figure 
S1A in the online-only Data Supplement). L-Tx pups demon-
strated an increase in heart weight at PD9, PD11, and PD20 
compared with S-Tx (Figure S1C) with no change in body 
weight (Figure S1B). L-Tx hearts were also heavier than S-Tx 
at day 30, and body and organ weights remained unchanged 
(Table S1). At 2 and 12 months, the heart weight in male and 
female L-Tx, as well as the inguinal fat mass, was increased 
relative to S-Tx (Table S2).
Leptin Challenge
Thirty-day-old L-Tx rats showed impaired anorectic responses 
to the leptin challenge compared with S-Tx, as demonstrated 
by an absence of a reduction in food intake or body weight 
over a 24-hour period (Figure S2A). At this time there was 
no increase in endogenous serum leptin or insulin concentra-
tion (Figure S3A and S3B). Leptin resistance was also pres-
ent at 2 months of age in L-Tx (Figure S2B), at which time 
endogenous serum leptin and insulin concentrations were sig-
nificantly raised compared with S-Tx (Figure S3A and S3B).
BP and Autonomic Function
At 30 days, L-Tx females had a higher mean arterial pres-
sure (MAP) and night-time heart rate (HR; active phase) 
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versus S-Tx (Figure 1B). L-Tx males showed increased 
night-time HR versus S-Tx (Figure 1A). Systolic BP was 
increased in L-Tx male (night-time) and female rats versus 
S-Tx (Figure S4A and S4B). Diastolic BP was similar in 
L-Tx and S-Tx (Figure S4A and S4B). Male L-Tx dem-
onstrated reduced locomotor activity versus S-Tx (P<0.05, 
Figure S4A).
At 2 months, there were no sex differences in BP, HR, 
or locomotor activity. L-Tx demonstrated increased day 
and night-time MAP (P<0.05 and P<0.001, respectively), 
whereas night-time HR was markedly reduced (P<0.001) 
versus S-Tx (Figure 1C). Night-time systolic BP (P<0.05) 
and day and night-time diastolic BP (P<0.001) were higher 
in L-Tx versus S-Tx (Figure S4C). There was no differ-
ence in spontaneous locomotor activity between groups 
(Figure S4C).
Spectral analysis of basal HRV showed an increased ratio 
of low-to-high frequency domains in 30-day-old L-Tx ver-
sus S-Tx, indicative of a dominant increase in sympathetic 
activity. Time domains of HRV, SD of normal to normal 
intervals and root mean square of successive differences, 
were similar in juvenile L-Tx and S-Tx. At 2 months of 
age, L-Tx (sexes combined) showed decreased SD of nor-
mal to normal intervals, high frequency, and increased low 
frequency and the ratio of low-to-high frequency versus 
S-Tx rats (Table S3).
Cardiovascular Reactivity to Stress and Renal NE
Thirty-day-old L-Tx females exhibited a higher MAP 
(P<0.01) and HR (P<0.05) response to 20 minutes of restraint 
versus S-Tx (Figure S5B). After 120 minutes, the MAP and 
HR remained elevated in both male and female L-Tx ver-
sus S-Tx in which cardiovascular responses had returned to 
baseline (Figure S5A and S5B). Renal NE content (at base-
line, no restraint) was increased 2-fold in L-Tx versus S-Tx 
(Figure S5C). Sympathetic inhibition by combined adminis-
tration of the α1-adrenergic receptor antagonist, terazosin, 
and the β1/β2-adrenergic receptor antagonist, propranolol, 
normalized MAP and led to a greater fall in basal MAP in 
L-Tx rats (sexes combined) versus S-Tx (Figure 2A and 2B).
BP Response to Leptin Challenge
At 30 days of age, intraperitoneal administration of leptin 
increased MAP in both L-Tx and S-Tx rats (sexes combined) 
within 2 hours (Figure 3A). The increase in MAP (ΔMAP) 
was twice as high in L-Tx versus S-Tx rats 6 hours post chal-
lenge (Figure 3B). MAP returned to baseline in all the animals 
by 8 hours (Figure 3A).
Figure 1. Mean arterial pressure (MAP) and 
heart rate (HR) in 30-day-old saline-treated 
(S-Tx; open circles) or leptin-treated (L-Tx; 
closed circles) male (A) and female (B) rats 
and 2-month-old male and female rats 
combined (C). ***P<0.001; **P<0.01; and 
*P<0.05 vs saline (repeated-ANOVA; n=4). 
BPM indicates beats per minute. 
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Cardiac Structure and Function
Thirty-day-old female L-Tx showed increased LV internal 
diameter at systole, increased LV volume at systole, and 
decreased intraventricular septal thickness at diastole versus 
S-Tx (Figure S6A). This was associated with a reduced ejec-
tion fraction and fractional shortening in female L-Tx versus 
S-Tx (Figure S6A; Table S4).
At 12 months, female L-Tx showed markedly increased LV 
mass, LV internal diameter at systole, and LV posterior wall at 
diastole (Figure S6B; Table S5). Female L-Tx also demonstrated 
impaired cardiac function with reduced ejection fraction and 
fractional shortening (Table S5). Male L-Tx showed increased 
LV mass and LV internal diameter at diastole (Table S5). 
No differences in function were observed between groups in 
male rats.
Isolated Hearts
Thirty-day-old male and female S-Tx and L-Tx showed pre-
served Frank-Starling responses to increased LV pressure 
(Figure S7A and S7B). At 5 months, Frank-Starling responses 
were similar in S-Tx and L-Tx, whereas L-Tx male hearts 
showed impaired LV systolic function at a given level of 
preload (160–260 µL), whereas diastolic stiffness remained 
unaffected (Figure S7A). No differences in cardiac systolic or 
diastolic function were observed in 5-month-old L-Tx females 
(Figure S7B).
Isoprenaline (10 nmol/L) stimulation resulted in a positive 
inotropic and chronotropic response in S-Tx and L-Tx hearts, 
which was independent of age (Figure S8). This chrono-
tropic response was blunted in male L-Tx versus S-Tx hearts 
at 30 days, although no differences in inotropic responses 
were observed (Figure S8A). No differences in inotropic or 
chronotropic response were observed in females at any age 
(Figure S8B).
Cardiomyocyte Morphology
Left ventricle myocyte cross-sectional area showed similar 
Gaussian distribution between the groups (Figure 4A). There 
was no significant mean difference in cross-sectional area 
between groups. Cardiomyocyte number per unit area was, 
however, increased in L-Tx versus S-Tx rats (Figure 4B). 
Histological examination showed no evidence of fibrosis in 
the perivascular or intramural vascular structures in L-Tx 
hearts at 30 days of age (Figure S9).
Discussion
We have previously reported that maternal diet-induced obe-
sity in rats is associated with juvenile hypertension, hyper-
phagia, and leptin resistance in the offspring.7 We implicated 
central pathways in the hypothalamus and proposed a causal 
role for the exaggerated and prolonged leptin surge observed 
in the neonatal offspring during the second postnatal week of 
life.7,9 Leptin plays a physiological neurotrophic role in hypo-
thalamic development during this critical period.18 We now 
demonstrate that exogenous leptin given to rat pups from lean 
Figure 2. Mean arterial pressure (MAP) response (A) and ΔMAP 
(B) to α1-adrenergic receptor antagonist, terazosin (10 mg/kg, 
IP), plus a β1/β2-adrenergic receptor antagonist, propranolol 
(10 mg/kg, IP) in 30-day-old saline-treated (S-Tx; open circles) 
or leptin-treated ( L-Tx; closed circles) male and female rats 
combined. ***P<0.001 vs saline-treated (prechallenge); *P<0.05 
vs saline-treated (15 min, A; 60 min, B; repeated-ANOVA; n=5–6).
Figure 3. Mean arterial pressure (MAP) response to leptin (10 
mg/kg, IP) in 30-day-old saline-treated (S-Tx; open circles) 
or leptin-treated (L-Tx; closed circles), male and female rats 
combined (A). Calculated average response to leptin and 
vehicle over 6 h post challenge (B). ***P<0.001 vs saline-treated 
(repeated-ANOVA); *P<0.05 vs saline-treated (t test; n=6–8). 
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dams during the same period leads to a similar phenotype and 
conclude that this hormone may play a key mechanistic role in 
the relationship between maternal obesity and cardiovascular 
and metabolic dysfunction of the offspring.
The serum concentration of leptin achieved in the pups by 
injection was higher (≈2-fold), but of the same order of mag-
nitude, as that at the peak of the neonatal leptin surge in the 
OffOb.9 Similar to the OffOb rats, juvenile L-Tx rats showed 
a loss of the inhibitory effects of leptin on food intake and 
body weight, at a time at which endogenous serum leptin was 
not raised, and this leptin resistance continued into adult life. 
This is consistent with previous reports showing that exog-
enous leptin treatment during early postnatal life in rodents 
leads to a permanent loss of the anorexic response to leptin 
and increased diet-induced weight gain in adulthood.18–20
In common with juvenile OffOb rats,7 L-Tx rats demon-
strated early onset hypertension, increased stress reactivity, 
renal NE content, and changes to the HRV and the heart 
rate relationship with BP, indicative of an increase in cen-
tral sympathetic activity. Further proof of sympathetically 
mediated hypertension was provided by normalization of 
the BP by pharmacological adrenoceptor blockade. Despite 
showing no increase in fat mass or hyperleptinemia at this 
age, these animals also demonstrated an increased pressor 
response to leptin, another characteristic of the OffOb rat.7 
This too implicates increased sympathetic efferent activity, 
as leptin plays an important cardiovascular regulatory role 
in the central nervous system.11 Infusion of leptin or leptin 
overexpression in adult mice increases renal sympathetic 
nerve activity and BP,10,12 whereas monogenic leptin defi-
ciency, in both humans and animals, leads to obesity, but 
protects against obesity-related hypertension.21,22 Several of 
these reports implicate a central role for the hypothalamus, 
also the site of leptin induced appetite regulation. Taken 
together the data suggest that the cardiovascular and appetite-
regulatory effects of neonatal leptin treatment are attributable 
to divergent effects on discrete signaling pathways resulting 
in selective leptin responsiveness in different regions of the 
hypothalamus, a hypothesis also proposed from leptin chal-
lenge studies in adult animals.11,12 Also, because there is evi-
dence of leptin receptors in the nucleus of the solitary tract 
which affect sympathetic efferent activation, a role for this 
cannot be discounted.23 Previously reported in adult animals 
and humans which are obese and hyperleptinemic,12,24 the 
concept that selective leptin responsiveness can be induced 
by early exposure to exogenous neonatal leptin is a novel 
observation. Overall, these observations lend strong support 
to our hypothesis that the exaggerated postnatal leptin surge 
in OffOb rats plays an essential role in the adulthood cardio-
vascular and metabolic profile previously reported.6,15
To our knowledge only 2 previous studies have assessed 
the influence of neonatal leptin on subsequent cardiovascular 
function. When leptin was administered to mice in the neo-
natal period (80 ng/g IP PND4-14), Erkonen et al25 measur-
ing BP with a tail cuff, reported reversal of hypertension in 
4-month-old mice which had been induced by neonatal growth 
restriction (achieved through large-litter rearing), but BP in 
normal weight pups was unaffected. Trevenzoli et al26 have 
recently described increased BP, also by the tail cuff method, 
in adult 150-day-old rats treated with leptin in the neonatal 
period (PD1–10), achieving concentrations comparable with 
the present study, but this could have arisen from the associ-
ated increase in body weight in adulthood. The novelty of the 
present study lies in the development of sympathetically medi-
ated hypertension in juveniles after neonatal L-Tx, before the 
development of hyperleptinemia and increased body weight, 
suggesting a direct influence of early leptin exposure on the 
developing pathways of BP control. Importantly, the use of 
radiotelemetry avoided stress activation of sympathetic tone, 
which can be induced by the tail cuff technique.
The BP profile in L-Tx and OffOb rats was not entirely sim-
ilar. Whereas at 30 and 90 days of age, both male and female 
OffOb rats had abnormal MAP,7 only L-Tx females demon-
strated a higher MAP. Leptin may, therefore, not be alone in 
playing an influential role. Fetal hyperinsulinemia also affects 
hypothalamic neurodevelopment,27 and the glucose intoler-
ance observed in obese rodent dams is likely to stimulate fetal 
insulin secretion.6,14
Persistent increase in heart weight has been observed in 
OffOb rodents.6,14 The alterations in cardiac function in juve-
nile L-Tx rats as assessed by echocardiography were similar 
to those we observed in a preliminary study in adult OffOb 
mice.28 Cardiac dilatation observed together with impaired 
contractility (ejection fraction, fractional shortening) may 
reflect a second decompensatory phase which may be a pre-
lude to myocardial failure in this model.29
Figure 4. Myocyte cross-sectional area (CSA; A) and number 
(B) from left ventricular (LV) myocardial sections of 30-day-old 
saline-treated (S-Tx) and leptin-treated (L-Tx) rats. A similar 
Gaussian distribution for LV myocyte CSA was observed 
between the groups (100 measurements per animal, 4 sections 
per animal). Increased cardiomyocyte number (myocyte/mm2)/mg 
heart weight (HW) was shown in L-Tx vs S-Tx. Values are 
measured per unit area from 6 fields per section, 4 sections per 
animal. *P<0.05 vs saline (t test). 
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As L-Tx rats were hypertensive at each age studied, the car-
diac abnormalities may occur simply as a result of an increase 
in BP and hemodynamic load or altered neurohumoral sig-
naling. Alternatively, leptin treatment in early life may have 
a persistent influence on cardiac structure; previous reports 
have shown that the addition of leptin to rat neonatal myocyte 
culture leads to hypertrophy17 or hyperplasia.16 Because the 
majority of rat cardiomyocytes undergo terminal maturation 
in early postnatal life,30 we hypothesized that postnatal hyper-
leptinemia could induce cardiac dysfunction in the juvenile 
animal through either of these processes. There was no evi-
dence of myocyte hypertrophy and we conclude that increased 
cardiac mass is a consequence of increased myocyte number, 
as calculated. Expansion of the extracellular matrix may play 
a role, but there was no histological evidence of fibrosis.
Sympathetic activation may stimulate heart growth.31 In the 
older animals, impaired contractility may also be influenced 
by hyperleptinemia.32
In male L-Tx rats, cardiac function gradually deteriorated 
with age, possibly related to secondary effects of increased 
adiposity, hyperleptinemia, and hyperinsulinemia. In contrast, 
in female L-Tx rats, age-related effects were not obvious, pro-
viding an example of sexual dimorphism, frequently observed 
in studies of developmental programming.33 There were also 
differences between female systolic function as assessed in 
vivo and ex vivo, implicating a role for neural or hormonal 
influences in vivo.
Care must be taken in extrapolating from animal models to 
the human condition. Rodents provide a convenient experi-
mental model, with a relatively fast life course, but they are 
altricial species born at an immature stage of development 
compared with humans. Considering the critical postnatal 
window in the current study, the equivalent period of devel-
opmental plasticity in the human hypothalamus is most likely 
the third trimester of pregnancy, but may extend into postnatal 
life, as demonstrated in nonhuman primates.34 The metabolic 
profiles in the adult OffOb rats show similarities to that found 
in nonhuman primates and in sheep, supporting translation to 
precocial species.5 The fetuses of obese pregnant women are 
exposed to hyperleptinemia as measured by cord blood leptin35 
and in mothers with type 1 diabetes mellitus, cord blood leptin 
correlates with childhood body mass index aged 7 years36 and, 
although seldom measured, BP has been reported to be raised 
in adult offspring of obese women.4
Perspectives
We propose that early life exposure to hyperleptinemia may 
directly predispose to early onset hypertension, hyperphagia, 
and cardiac dysfunction. Mechanistically this may involve the 
hypothalamus. We have previously shown impaired develop-
ment of the agouti-related protein pathway in the hypothala-
mus of juvenile OffOb rats.9 Agouti-related protein is the 
endogenous antagonist of the melanocortin-4 receptor; there-
fore, a reduced antagonism may increase melanocortin-4 
receptor signaling at sites relevant to BP regulation and con-
sequently to hypertension,37 a concept open to exploration 
with specific pharmacological agents. This study also opens 
avenues of exploration in animal models and in humans to 
address the role of early life leptin exposure in early onset 
essential hypertension. Most importantly, ongoing mother–
child cohort in obese pregnant women should address associa-
tions between maternal obesity and offspring cardiovascular 
function in young children, and through to adulthood.
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What Is New?
•	Neonatal exposure to hyperleptinemia in rodents leads to early onset 
hypertension, hyperphagia, and cardiac dysfunction, before the develop-
ment of hyperleptinemia and obesity.
•	Hyperleptinemia in the immediate postnatal period leads to an adult phe-
notype similar to that described in offspring of obese rodents.
•	 Increased leptin exposure secondary to maternal obesity may predispose 
to early hypertension and heart failure.
What Is Relevant?
•	High leptin concentrations, secondary to maternal obesity might consti-
tute a cardiovascular risk for the offspring.
•	This study suggests 1 potential mechanism for the development of early 
essential hypertension.
Summary
Neonatal hyperleptinemia plays an important role in the develop-
mental origin of hypertension, secondary to maternal obesity in 
rodents. Exposure to leptin during critical periods of development 
also influences cardiac structure and function in a way which may 
predispose to heart failure in adulthood.
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Expanded Materials and Methods 1 
Telemetry and heart rate variability  2 
Baseline systolic blood pressure (SBP), mean arterial pressure (MAP), diastolic blood 3 
pressure (DBP), heart rate (HR) and physical activity were measured in S-Tx and L-Tx rats at 4 
30 days and 2 months of age using radiotelemetry. 1 Briefly, rats were anesthetized with 2 % 5 
isoflourane in O2 at 2 l per minute with pre- and post-operative analgesia (buprenorphine, 0.1 6 
mg kg–1S.C.). In juvenile rats (23 days), a small transmitter designed for the mouse (DSI 7 
PhysioTel® PA-C10) was implanted in the aortic arch via the left carotid artery. 2 In adult 8 
rats (50 days), the standard rat telemetry blood pressure probe (DSI PhysioTel® PA-C40; 9 
Data Sciences International) was placed in the descending abdominal aorta as previously 10 
described. 3 Following one week of recovery, rats housed in individual cages were placed 11 
above the telemetric receiver. Cardiovascular variables and physical activity were routinely 12 
monitored in a quiet room by scheduled sampling for 10 seconds every 5 minutes with A.R.T. 13 
10 software (Dataquest 3.01, DSI, St Pauls, MN). Data reported are for a single 24 hour 14 
period.  15 
Heart rate variability (HRV) was analysed from a 300 seconds continuous telemetric BP 16 
record (HR derived from pressure waves) using spectral analysis. Data sets recorded in a 17 
sinus rhythm with sampling frequency 500 Hz were used.  Time and frequency domain of 18 
HRV analysis were performed using HRV module of Chart 5.0 analysing software 19 
(ADInstruments, Colorado Springs, CO). Ectopics and visible short artefacts were manually 20 
excluded or replaced by intervals linearly interpolated from the nearest normal interval to 21 
avoid discontinuity in the record. Spectral powers of BP signals were analysed with the 22 
LabVIEW 7.1 (National Instruments, MA). Spectral segments were set to 0.20-0.60 Hz for 23 
low frequency (LF), which is an index of both sympathetic and parasympathetic activity, and 24 
0.6-2.5 Hz for high frequency (HF), which is an index of parasympathetic nervous activity. 4 25 
The power and frequency of every spectral component are presented in absolute units.  26 
Power (in m2) was estimated as the area under the spectrum within these frequency ranges. 27 
Beat-by-beat time series of blood pressure waveform were generated, and series of pulse 28 
intervals (PI) were obtained by measuring the intervals between consecutive BP waves. In the 29 
time-domain, the following indices were obtained: R-R (mean R-R interval), SDNN 30 
(standard deviation of normalised R-R intervals) and RMSSD (root mean square of 31 
successive differences of R-R intervals). 32 
Cardiovascular responses to restrain stress and adrenergic receptor blockade  33 
Telemetered animals were subjected to stress using a humane Perspex whole body restraining 34 
cylinder. The size of the cylinder was selected according to body size. Cardiovascular 35 
parameters were recorded in animals 30 minutes before the stress, 20 minutes during the 36 
stress and for 120 minutes after return to the home cage. Experiments were performed 37 
between 0900 and 1000 hours. Scheduled sampling was implemented for 10 seconds every 38 
minute (Dataquest LabPRO Aquisition System version 3.01, DSI, St Pauls, MN). 39 
Two days after the stress test a sub-group of animals received a combination of the α1 40 
adrenergic receptor antagonist, terazosin (10mg/kg, i.p), plus the β1/β2 adrenergic receptor 41 
antagonist, propranolol (10mg/kg, i.p, Sigma –Aldrich Ltd, Poole, UK). Cardiovascular 42 
parameters were recorded for 30 minutes before the injection (baseline) and then for 10 43 
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seconds every minute for 2 hours after the injection. The receptor blockade achieved with this 1 
protocol has been previously demonstrated. 5 2 
Cardiovascular response to leptin  3 
Randomly selected age-matched littermates were given a single bolus dose of IP leptin  (10 4 
mg/kg BW; PeproTech) or vehicle. The pressor effects were assessed before and 6 hours after  5 
injection, using scheduled sampling (10 seconds every 15 minutes).  6 
Echocardiography  7 
Prior to the imaging studies, the rat was anesthetized (2-3% isoflurane mixed with 0.5 L/min 8 
100% O2) in the induction chamber. The investigator was blind as to whether the animals had 9 
been treated with saline or leptin in the neonatal period. After loss of the righting reflex, animals 10 
were placed on a warming platform and an appropriately sized nose cone was placed over the 11 
animal’s nose. Anaesthesia was maintained using 0.5-1% isoflurane. Temperature was 12 
monitored with a rectal thermometer and maintained ~37 ºC. Echocardiograms were 13 
performed using a Vevo 770 High Resolution Imaging System (VisualSonics, Toronto, ON, 14 
Canada) with a RMV-707B transducer running at 30MHz (in juvenile rats) and a RMV701B 15 
transducer running at 28MHz for the adult rats. High-resolution, 2- dimensional B-mode and 16 
M-mode images at the level of the papillary muscles were acquired. The following 17 
parameters were assessed in end-systolic and end-diastolic situation: thickness of the 18 
interventricular septum (IVS), left ventricle posterior wall thickness (LVPW), left ventricle 19 
inner diameter (LVID) and left ventricle volume (LVVol). Ejection fraction (EF), fractional 20 
shortening (FS), stroke volume (SV) and cardiac output (CO) were calculated with Vevo 21 
Software (VisualSonics). Measurements were made of the interventricular septum in diastole, 22 
left ventricular internal dimension in diastole, left ventricular internal dimension in systole 23 
and left ventricular posterior wall in diastole. These measurements were then used to 24 
calculate the left ventricular fractional shortening (FS), ejection fraction (EF), stroke volume 25 
(SV) and cardiac output (CO). Measurements were made in accordance with the American 26 
Society for Echocardiography Guidelines. 6 27 
Isolated Perfused Heart Preparation  28 
At the age of 30 days or 5 months, hearts were excised and studied in a Langendorff isolated 29 
heart preparations. Age-matched rats were anesthetised with sodium pentobarbital (200 30 
mg/kg and 200 IU/kg, respectively, ip). Hearts were rapidly excised, placed in cold Krebs-31 
Henseleit buffer (KHB) and cannulated via the aorta. Hearts were then perfused with 32 
oxygenated (95% O2 and 5% CO2) KHB at 37.0°C (pH 7.4) in a retrograde Langendorff 33 
perfusion system at a constant pressure equivalent to 72±1 mmHg using a peristaltic pump 34 
and a feedback-system controlled by an STH Pump Controller (AD Instruments, Aus). The 35 
KHB contained (in mM) 118.5 NaCl, 4.7 KCl, 1.18 KH2PO4, 25.0 NaHCO3, 1.2 MgCl2, 1.4 36 
CaCl2 and 11.1 glucose. Measures of cardiac contractile function, such as left ventricular 37 
developed pressure (LVDP) and HR, were performed with a liquid-filled balloon inserted 38 
into the left ventricle. After the baseline was established (~25 minutes), the pressure-volume 39 
Frank-Starling response was assessed by increasing the balloon volume in 20µl increments 40 
every minute, using a pre-calibrated syringe, until the new steady state was reached. The 41 
assessment of the Frank-Starling response was completed within 15 minutes and the balloon 42 
was deflated to the baseline level (left ventricle developed pressure, LVEDP, between 4-8 43 
mmHg) for 5 minutes. Hearts were then perfused with KHB with isoprenaline (10nM) for 44 
further 15 minutes.  45 
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Immunohistochemistry  1 
Immediately after euthanasia at postnatal day 30, the heart was snap-frozen in an isopentane-2 
dry ice slurry and stored at -80ºC. The cardiac ventricles were cut (at 7µm) with a cryostat in 3 
horizontal sections at the midventricular short axis, mounted on poly-lysine-coated glass 4 
slides and fixed with ice-cold 4% PFA for 15 minutes. After removal of the fixative, sections 5 
were permeabilized by the addition of 0.1% Triton-X-20 in PBS (Sigma-Aldrich, UK). 6 
Sections were then incubated overnight at room temperature with a rabbit anti-laminin 7 
(1:300, DakoCytomation, Glostrup, DE). Slides were then washed 3 times for 5 minutes with 8 
0.1% Triton-X-20 in PBS. A secondary antibody, fluorescein (FITC)–conjugated goat anti-9 
rabbit IgG (1:400, Invitrogen, Carlsbad, CA) was applied for 2 hours then washed 3 times. 10 
Slides were cover-slipped and examined by a fluorescence light microscope.  11 
Image Acquisition 12 
Laminin stained sections were used to quantify cardiomyocyte cross-sectional area (CSA) 13 
and number. Digital images for laminin (green) staining were captured at x40 objective from 14 
two non-overlapping fields (left ventricle) from each section (4 adjacent sections per heart), 15 
using the AxioCam CCD digital camera (Carl Zeiss, Oberkochen, Germany) mounted to an 16 
inverted epifluorescence microscope (AxioVert 135; Carl Zeiss). The CSA of individual 17 
cardiomyocytes was quantified as previously described. 7 For cell size, CSA was outlined 18 
from 100 measurements per animal, 4 sections per animal, by two independent investigators 19 
blind to the animal group. For cell number, myocytes were counted from 6 randomly selected 20 
fields (x40 objective) per section, 4 sections per animals and expressed as number of 21 
myocytes per unit area (1mm2).  22 
Test for Fibrosis 23 
Hearts were isolated and fixed with 4% formaldehyde, dehydrated and embedded in paraffin. 24 
Global heart architecture was determined from 5µm deparaffinized sections stained with 25 
hematoxylin and eosin (H&E). The possible presence of fibrosis was checked with Masson’s 26 
Trichrome staining.  27 
 28 
  29 
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Tables and Figures  
 
  
 
  
Male Female
Weight S-Tx L-Tx S-Tx L-Tx
Body weight (g) 63.5±2.6 65.2±1.2
62.0±1.1 63.5±1.9
Inguinal WAT (g) 0.18±0.03 0.20±0.03 0.15±0.03 0.14±0.01
Heart weight (g) 0.35±0.02 0.41±0.01* 0.35±0.01 0.42±0.01*
Liver weight (g) 2.53±0.13 2.58±0.10 2.33±0.10 2.60±0.32
Heart weight (g/kg BW) 5.53±0.17 6.34±0.28* 5.64±0.18 6.52±0.09*
Liver weight (g/kg BW) 40.2±2.9 39.1±1.7 38.7±2.0 42.3±2.6
Values given as mean+ SEM *P<0.05 versus saline treated using t-test, n=4-8. 
Table S1. Body weight, inguinal WAT, and heart -weight in 30 day- old male and female rats treated with 
saline (S-Tx) or leptin (L-Tx) in neonatal period. 
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2 months 12 months
Male Female Male Female
Weight S-Tx L-Tx S-Tx L-Tx S-Tx L-Tx S-Tx L-Tx
BW (g) 222.9±6.9 238.2±12.1 188.5±10.9 194.9±9.19 600.0±29.6 631.3±23.7 346.8±7.2 402.2±17.2†
Inguinal 
WAT (g) 
1.32±0.15 2.03±0.35* 1.01±0.15 1.86±0.05† 5.31±0.41 9.25±1.21† 5.23±0.76 12.3±1.35‡
Heart 
weight (g)
0.87±0.02 1.12±0.09* 0.71±0.02 0.82±0.03* 1.61±0.03 1.77±0.03* 1.19±0.03 1.56±0.10†
Liver 
weight (g) 
9.08±0.29 8.82±0.29 7.35±0.79 7.57±0.79 16.81±0.42 19.12±1.00 9.16±0.60 10.77±0.05
Table S2. Body weight, inguinal WAT, heart, and liver weight in 2 and 12 month old male and female rats treated with saline or leptin in neonatal period. 
*P<0.05, †P<0.01, ‡P<0.001 versus saline treated using t-test, n=4-8. Abbreviation S-Tx saline treated, L-Tx leptin treated, BW body weight, WAT 
white adipose tissue. 
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30 days 2 months
Male Female Male + Female 
Parameters S-Tx L-Tx S-Tx L-Tx S-Tx L-Tx
SDNN (ms) 7.9 ±1.3 4.8±0.8 3.4±0.4 2.7±0.5 8.1 ±0.3 3.2±0.2*
RMSSD (ms) 3.6±0.5 3.1±1.2 3.1±0.4 2.0±0.6 2.9±0.6 2.4±0.3
AverageHR (bpm) 372.3±9.1 370.1±7.7 342.0±9.9 342.0±15.1 400.1±10.2 406.2±4.1
RR (mean m2) 161.5±4.0 162.3±3.5 175.6±4.9 172.9±7.5 149.2±3.1 138.2±0.9
LF (ms2) 4.8±1.6 6.8±1.7 0.7±0.3 1.0±0.5 3.2±0.4 9.2±0.1*
HF (ms2) 9.5±4.2 8.5±4.2 3.6±0.9 2.3±1.2 6.5±1.2 3.2±0.3*
LF/HF 0.6±0.1 0.8±0.1* 0.2±0.1 0.5±0.1* 0.5±0.1 2.9±0.1‡
Table S3. Heart rate variability in 30 day- and 2 month old male and female rats treated with saline or leptin in neonatal period.
Values given as mean+ SEM *P<0.05, ‡P<0.001, versus saline treated using t-test, n=6-8 for leptin treated L-Tx versus saline treated S-Tx, 
using t-test, n=4-8. Time and frequency domains of the heart rate (HR) variability identify differences in the high frequency domain (HF; 
0.60-2.5 Hz), corresponding to parasympathetic activity, and in the low frequency domain (LF, 0.20-0.60 Hz) corresponding to preliminary 
sympathetic activity. 4 Power (in m2) was estimated as the area under the spectrum within these frequency ranges. Beat-by beat time series 
of blood pressure waveform were generated, and series of pulse intervals (PI) were obtained by measuring the intervals between consecutive 
BP waves. In the time-domain, the following indices were obtained: R-R (mean RR interval), SDNN (standard deviation of normalised R-R 
intervals) and RMSSD (root mean square of successive differences of R-R intervals). 
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Male Female
Structure & Function S-Tx L-Tx S-Tx L-Tx
LVmass (mg) 282.8±10.0 281.6±12.0 284.1±13.9 271.6±10.5
LVVol;d (µl) 151.0±11.0 157.4±3.7 147.8±5.0 144.1±7.7
LVVol;s (µl) 43.3±7.02 38.8±2.3 28.8±2.3 34.8±3.1*
LVIDd (mm) 5.4±0.08 5.5±0.09 5.2±0.07 5.2±0.09
LVIDs (mm) 3.3±0.11 3.3±0.07 2.8±0.04 3.2±0.14*
LVPWd (mm) 1.3±0.03 1.2±0.07 1.3±0.03 1.2±0.04
LVPWs (mm) 1.9±0.13 2.0±0.10 2.0±0.08 1.8±0.11
SV (µl) 107.6±5.4 118.6±2.7 118.9±5.2 109.3±5.9
EF (%) 67.6±2.0 69.7±0.9 75.7±1.0 67.9±2.6*
FS (%) 38.2±1.6 39.8±0.7 45.0±1.0 38.5±2.0*
CO (ml/min) 43.7±2.7 46.5±1.8 52.6±2.9 45.8±2.8
HR (bpm) 406±9 395±9 438±13 420±11
Table S4. Echocardiographic parameters measured in 30 day old male and female rats treated with saline or leptin
in neonatal period.
Values are given as mean + SEM *P<0.05 versus saline treated by t-test, n=4-8. Abbreviation S-Tx saline treated,
L-Tx leptin treated. Left ventricular anterior wall at diastole (LVAW:d); Left ventricular anterior wall at systole
(LVAW:s); Left ventricular internal dimension at diastole (LVID:d); Left ventricular internal dimension at systole
(LVID:s); Left ventricular posterior wall at diastole (LVPW:d); Left ventricular posterior wall at systole (LVPW:s);
From the PLAX view, the following measurements were obtained Intraventricular septum at diastole (IVS:d), mm;
Intraventricular septum at systole (IVS:s), mm; Left ventricular internal dimension at diastole (LVID:d), mm; Left
ventricular internal dimension at systole (LVID:s), mm; Left ventricular posterior wall at diastole (LVPW:d), mm;
Left ventricular posterior wall at systole (LVPW:s), mm; Left ventricular internal volume at diastole (LVVol:d), ml;
Left ventricular internal volume at systole (LVVol:s), ml; Stroke volume (SV), ml/min; Ejection Fraction (EF), %;
Fractional Shortening (FS), %; Cardiac Output (CO).
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Male Female
Structure & Function S-Tx L-Tx S-Tx L-Tx
LVmass (mg) 949.3±57.0 1217.6±45.1* 790.3±20.8 1005.3±72.5*
LVVol;d (µl) 316.1±45.9 378.3±59.6 345.8±6.6 392.7±26.9
LVVol;s (µl) 112.5±8.3 150.7±33.9 101.3±5.3 155.2±25.9*
LVIDd (mm) 7.8±0.22 8.9±0.05* 4.7±0.13 8.0±0.12
LVIDs (mm) 5.0±0.05 5.7±0.26 4.7±0.13 5.3±0.13*
LVPWd (mm) 2.0±0.04 2.0±0.18 1.8±0.04 2.2±0.15*
LVPWs (mm) 3.0±0.15 3.0±0.13 2.9±0.19 2.9±0.13
SV (µl) 203.7±37.8 227.6±28.2 244.5±3.4 237.6±15.2
EF (%) 63.5±3.2 61.1±3.8 70.8±1.1 61.1±4.8*
FS (%) 36.0±2.5 34.3±2.6 41.7±1.0 34.6±3.6*
CO (ml/min) 75.9±16.3 75.3±10.4 77.4±2.6 77.9±6.1
HR (bpm) 370.3±24 329±12 317±13 327±9
Table S5. Echocardiographic parameters measured in 12 month old male and female rats treated with saline or 
leptin in neonatal period.
Values are given as mean + SEM *P<0.05 versus saline treated by t-test, n=3-6. Abbreviation S-Tx saline treated, 
L-Tx leptin treated. Left ventricular anterior wall at diastole (LVAW:d); Left ventricular anterior wall at systole 
(LVAW:s); Left ventricular internal dimension at diastole (LVID:d); Left ventricular internal dimension at systole 
(LVID:s); Left ventricular posterior wall at diastole (LVPW:d); Left ventricular posterior wall at systole (LVPW:s); 
From the PLAX view, the following measurements were obtained Intraventricular septum at diastole (IVS:d), mm; 
Intraventricular septum at systole (IVS:s), mm; Left ventricular internal dimension at diastole (LVID:d), mm; Left 
ventricular internal dimension at systole (LVID:s), mm; Left ventricular posterior wall at diastole (LVPW:d), mm; 
Left ventricular posterior wall at systole (LVPW:s), mm; Left ventricular internal volume at diastole (LVVol:d), ml; 
Left ventricular internal volume at systole (LVVol:s), ml; Stroke volume (SV), ml/min; Ejection Fraction (EF), %; 
Fractional Shortening (FS), %; Cardiac Output (CO).
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Figure S1 
 
 
 
 
 
 
Figure S1. Neonatal serum leptin concentration (A), body weight (B) and heart weight (C) in 
leptin (3 mg/kg ip) and saline treated pups (male and female combined). ***P<0.001, 
**P<0.01 versus saline using t-test, n=4-7.  
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Figure S2 
 
 
 
  
 
 
Figure S2. Weight gain and food intake recorded over 24 hours following a bolus leptin challenge (10 mg/kg i.p.) in saline-treated (S-Tx) or 
leptin-treated (L-Tx) male and female rats following an overnight fast at (A) 30 days and (B) 2 months of age. ***P<0.001, **P<0.01, *P<0.05 
versus saline injection using t-test, n=4-8 Abbreviation S-Tx-saline treated; L-Tx-leptin treated  
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Figure S3 
           
Figure S3. Serum leptin (A) and insulin (B) concentrations in saline-treated (open bars) or leptin-
treated (closed bars) male and female rats at 30 days, 2 months and 12 months of age. ***P<0.001, 
**P<0.01, *P<0.05 versus saline using t-test, n=5-8. Abbreviation M-male: F-female. 
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Figure S4 
   
 
 
 
Figure S4. Systolic blood pressure (SBP), Diastolic blood pressure (DBP) and Spontaneous 
Locomotor Activity (arbitrary units) in 30 day old saline-treated (open circles) or leptin-
treated (closed circles) male (A) and female (B) rats and 2 month old male and female rats 
combined (C). ***P<0.001, **P<0.01, *P<0.05 versus saline using repeated ANOVA, n=4-5. 
Abbreviation S-Tx-saline treated; L-Tx-leptin treated. 
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Figure S5 
 
 
 
Figure S5. Mean arterial pressure (MAP) and heart rate (HR) response to retraint stress in 30 
day old saline-treated (open circles) or leptin-treated (closed circles) male (A) and female (B) 
rats and renal NE content (C). ***P<0.001, **P<0.01, *P<0.05 versus saline using repeated-
measures ANOVA and t-test, n=5-8. Abbreviation S-Tx-saline treated; L-Tx-leptin treated.  
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Figure S6 
 
 
 
 
 
Figure S6. Cardiac structure and function from ultrasound analysis of saline-treated (open bars) and leptin-treated (closed bars) female rats 
at (A) 30 days and (B) 12 months of age. *P<0.05 versus saline using t-test, n=4-6. Abbreviation S-Tx-saline treated; L-Tx-leptin treated. 
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Figure S7 
 
 
 
Figure S7. Frank-Starling response of isolated Langendorff perfused heart of saline-treated 
(open circles) or leptin-treated (closed circles) male (A) and female (B) rats at 30 days and 5 
months of age. *P<0.05 versus saline using repeated t-test, n=6-10. Abbreviation S-Tx-saline 
treated; L-Tx-leptin treated.
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Figure S8 
 
 
 
 
Figure S8. Frank-Starling response of isolated Langendorff perfused heart of saline-treated (open circles) or leptin treated (closed circles) 
male (A) and female (B) rats at 30 days and 5 months of age. *P<0.05 versus saline using repeated t-test, n=6-10. Abbreviation S-Tx-saline 
treated; L-Tx-leptin treated. 
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Figure S9. Representative images of H&E and Masson’s Trichrome stained heart  
sections from 30 day old S-Tx and L-Tx rats. No fibrotic lesions were apparent.  
Scale bars: 100µm 
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